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Abstract 
BACKGROUND: One of the common complications of diabetic patients is sclerodactyly which is considered as a 
part of limited joint mobility. 
AIM: To assess sclerodactyly in adolescent type 1 diabetics and to detect its relation to other diabetic 
complications. 
METHODS: Sixty-three diabetics and 60 controls were studied. Clinical, laboratory assessment, ultrasonography 
of the skin, carotid artery intima-media thickness (cIMT) & renal colour duplex were done for all participants. 
RESULTS: Sclerodactyly was positive in 12 (19%) of diabetics. Patients with sclerodactyly had a significantly 
thickened skin compared to patients without sclerodactyly and controls, P = 0.0001. Male diabetics had 
significantly thickened skin (p = 0.0001). Diabetic patients with sclerodactyly had significant higher systolic blood 
pressure (p = 0.03), cholesterol (p = 0.05) and triglyceride (p = 0.004) and lower HDL-c (p = 0.04). Skin thickness 
had a significant positive correlation with age of diabetic patients (p = 0.02), waist/height ratio (p = 0.04), 
glycosylated hemoglobin (p = 0.03), albumin/creatinine ratio (p = 0.03), and cIMT (p = 0.03). 
CONCLUSION: Ultrasound easily diagnoses sclerodactyly. Diabetic patients had a high prevalence of 
sclerodactyly with increased macrovascular and microvascular complications. Sclerodactyly may be a marker for 
diabetic vascular complications. Frequent follow up of diabetic patients for early detection of sclerodactyly in 
uncontrolled diabetic patients is recommended. It could be an alarming sign for microalbuminuria, hypertension, 
hyperlipidaemia and atherosclerosis. 
 
 
 
 
Introduction 
 
Type 1 Diabetes Mellitus (DM) is associated 
with significant morbidity due to microvascular and 
macrovascular complications as well as several 
cutaneous & musculoskeletal manifestations including 
sclerodactyly and limited joint mobility (LJM) 
syndrome [1], [2]. 
Diabetic musculoskeletal, connective tissue & 
cutaneous complications have not been paid attention 
as other diabetic microvascular and macrovascular 
complications. The hand is frequently affected, 
resulting in both disability and deformity, especially in 
longstanding diabetics with poor glycemic control. 
Progressive alterations in connective tissue due to 
glycosylation of proteins, microangiopathy and 
peripheral neuropathy, along with collagen deposition 
in the skin and periarticular structures are the most 
likely explanations for the pathogenesis of these 
diabetic complications. Early diagnosis of these 
complications is of paramount importance in the 
routine care for diabetic patients as evidence indicate 
that diabetes control prevent progressive deformity 
and disability, prevent progression of associated 
diabetic microvascular and macrovascular 
complications and maintaining reasonable quality of 
life in diabetic patients [3], [4], [5], [6], [7]. 
Sclerodactyly, being a part of limited joint 
mobility syndrome (LJMS), or diabetic 
cheiroarthropathy, that is a condition characterised by 
hand stiffness resulting from flexion contractures of 
the fingers with thickened, tight, waxy skin [1]. 
However, these skin changes were also detected in 
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patients with DM who did not have LJM (and have 
been referred to as “diabetic sclerodactyly”). Seibold 
[8] detected skin changes in 34% of diabetic children 
compared with absent skin changes in healthy 
children; 20% of the diabetic patients had involvement 
limited to the proximal interphalangeal (PIP) joints, 
and distally, 10% had changes extending to the 
metacarpophalangeal (MCP) joints, and only 4% had 
skin changes proximal to the MCP joints. Skin 
thickness in the patient’s hands is assessed by 
attempting to tent the skin on the dorsum of the 
fingers between the examiner’s thumb and index 
finger. When skin changes are severe, loss of the 
transverse digital skin ridges on the dorsum of the 
fingers is obvious. 
Collier et al., [6] used ultrasonography to 
study skin thickness in 92 patients with DM and 40 
without. They found that skin thickness increases with 
the duration of DM and is closely related to the 
presence of LJM. Also, limited biopsy studies have 
revealed thickening of the dermis along with the 
accumulation of connective tissue in the lower dermis 
and a paucity of glands and hair follicles in diabetic 
patients [7], [9], [10]. 
Lieberman et al., [11] showed that insulin 
pump treatment of juvenile diabetic patients 
diminished the skin thickness with a concurrent 
decrease in the levels of HbA1c, lending support to a 
metabolic rather than an underlying immunological 
cause. In sclerodactyly, laboratory and radiographic 
evaluation are usually unremarkable with normal 
erythrocyte sedimentation rate, negative antinuclear 
antibodies, negative rheumatoid factor and normal 
results of nail fold capillaroscopy [12], [13]. 
LJM, including sclerodactyly, is a common 
complication of DM, occurring in 8% to 58% of 
patients; most studies suggest a prevalence of about 
30% to 40%. [10], [14], [15]. Recent studies [16], [17] 
revealed a reduced frequency of LJM compared with 
the frequency 2 decades ago. Lindsay JR et al., [17] 
stated that the incidence of LJMS & sclerodactyly has 
fallen from 43% to 23% between the 1980s and 2002 
(P < 0.0001) and attributed this to improved glycemic 
control and diabetic care. 
Rosenbloom and associates [10] reported that 
after 16 years of juvenile DM, patients with LJM had a 
more than 3-fold greater risk of clinically apparent 
microvascular disease (retinopathy and nephropathy) 
than those who did not have LJM. Also, Fitzcharles 
and coworkers [18] found a similar but less dramatic 
association of the microvascular disease with LJM in 
adult patients with DM. 
The authors of the Oxford Regional 
Prospective Study tried to explore the temporal 
relationship between the development of LJM and 
microvascular complications [19] and stated that 
although the albumin to creatinine ratio was higher in 
patients with LJM than in those without LJM, there 
was no difference between the groups in the 
prevalence of microalbuminuria, but after disease 
onset, the presence of microalbuminuria was 
increased in patients with LJM. The authors 
concluded that the presence of LJM confers a 1.9-fold 
increased risk of this complication. 
Arkkila and associates [20] found a 3.1-fold 
higher risk of coronary heart disease and a 4-fold 
higher risk of cerebrovascular disease in patients who 
had type 2 DM with LJM. 
So, sclerodactyly is one of the most important 
cutaneous manifestations of diabetes and was 
included as a part of the limited joint mobility 
syndrome (LJMS) in most previous studies while few 
studies focused on sclerodactyly as a separate entity. 
In the current study, we focus on 
sclerodactyly as a separate entity and its relation to 
the duration of diabetes, diabetic control, lipid profile, 
microvascular & macrovascular diabetic 
complications. 
 
 
Patients and Methods 
 
Approval of ethical committee, National 
Research Centre, Registration number 11052 and 
written consent was taken from diabetics or their 
parents and controls of this cross-sectional 
observational study. 
Sixty-three type 1 diabetic patients from the 
endocrine clinic, Medical Center of Excellence, 
National Research Centre and 60 age and sex-
matched healthy normal volunteers were enrolled in 
the study. 
Young diabetic patients (age > 14 and < 19 
yrs) and more than 5 years duration of diabetes were 
selected to explore whether sclerodactyly starts at this 
early age shortly after the onset of diabetes or needs 
longer exposure to the diabetic milieu. 
Patients suffering from acute diabetic 
complications, cardiac diseases, receiving metformin 
or multivitamins or Smokers were excluded from the 
study. Also, patients had any type of hand disorders 
like hand injury, Dupuytren's contracture, flexor 
tenosynovitis and scleroderma (scleroderma 
diagnosed by history, physical examination, tapering, 
fingertips ulceration, calcinosis, dystrophy with 
necrosis of fingernails, Raynaud’s phenomena) were 
excluded from the study. 
Demographic data of diabetic patients was 
taken. Also, data of the presence of any disease ( 
cardiac, renal, neurological, scleroderma or any 
autonomic dysfunction) were obtained.  
Clinical examination (general, cardiac, chest, 
neurological and hand) were done to al diabetics and 
controls.  
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Blood pressure was assessed three times, 
and the mean of second and third measurement was 
reported. 
Weight, height, waist circumference (WC), 
and hip circumference (HC) were measured for 
diabetics and controls. Weight and height were 
measured by Seca Scale Standing Balance and a 
Holtain Portable anthropometer (Holtain, Ltd, 
Crymmych, Wales, U.K). Body mass index, waist/hip 
ratio and waist/height ratio (cm/cm) were calculated 
[21], [22]. After 12 hr fasting, venous blood was 
collected for measurement of lipid profile [23]. Also, in 
a sterile EDTA vacutainer tube, venous blood samples 
were obtained for measuring glycated haemoglobin 
(HbA1c). The mean value of HbA1c (HbA1c was 
assessed every 3 months, and the mean value was 
calculated for one year) was calculated. 
Screening for microalbuminuria was assessed 
in fresh morning urine samples by measuring 
albumin/creatinine ratio. Microalbuminuria was 
measured 3 times (separated every 2 months), and it 
considers positive if 2 from 3 samples were positive 
[24]. Antinuclear antibodies (ANA), anti-Scl-70 and 
anti-centromere antibodies were also assessed in all 
people with diabetes included in the study. 
Ultrasonographic assessment of skin 
thickness: Epidermis plus dermis layers thickness was 
defined as skin thickness by using an ATL HDI 5000 
ultrasound machine (Phillips Healthcare, Best, 
Netherlands) equipped with a 12-5 MHz linear array 
transducer [25], [26].  Assessment of Carotid intima-
media thickness (cIMT) was done by using General 
Electric medical ultrasonographic machine model: 
Vivid 7 Pro, GE Vingmed ultrasound AS-Nl90, Horton-
Norway equipped with 7.5-10 MHz linear-array 
transducer) [27]. 
 
Renal colour duplex 
The renal colour duplex scan was done by 
using 3-6 MHz convex array transducer (Toshiba, 
Xario ultrasound machine). We measured in both 
renal arteries the peak systolic velocities and 
excluded renal artery stenosis in all patients by 
evaluation of different segments starting from their 
origins to renal hila. After that, resistivity indices were 
assessed in both sides in the segmental, interlobar 
and arcuate arteries [28]. 
 
Statistical Analysis 
Statistical analysis was conducted using 
Statistical Package for Social Science (SPSS) 
program version 20.0 (Chicago, Illinois, USA), t-test or 
Mann Whitney – U test (for non-symmetrically 
distributed data) for quantitative variables was done. 
One-way ANOVA test was done for analysis of more 
than 2 quantitative data followed by post HOCC test 
for detection of significance. Pearson
,
s or spearman 
correlation was also done. 
Results 
 
Antinuclear antibodies (ANA), anti-Scl-70 and 
anti-centromere antibodies were negative in all people 
with diabetes included in the study.  
Comparison between diabetic patients and 
controls was shown in Table 1.  
Table 1: Comparison between diabetic patients and controls 
Variables 
Patients Controls 
P-value 
Mean SD Mean SD 
Demographic data 
     
Age of patients (yrs) 17.99 2.59 17.50 2.67 0.60 
Duration of the disease (yrs) 10.91 3.54 -- -- -- 
Onset of disease (yrs) 7.00 3.28 -- -- -- 
Insulin dose (U/kg) 1.26 0.44 -- -- -- 
Blood pressure 
     
Systolic blood pressure (mmHg) 118.45 13.33 123.75 10.61 0.30 
Diastolic blood pressure (mmHg) 76.55 10.06 80.00 10.69 0.40 
Anthropometric data 
     
Midarm circumference (cm) 75.14 379.53 25.79 4.41 0.30 
Waist circumference (cm) 82.83 11.21 74.56 11.23 0.04 
Hip circumference (cm) 94.60 10.32 85.19 13.32 0.02 
BMI (kg/m
2
) 24.44 3.89 21.86 6.47 0.20 
Waist/hip ratio 0.88 0.08 0.88 0.07 0.90 
Waist/height ratio 0.51 0.07 0.48 0.10 0.30 
Laboratory data 
     
HbA1c (%) 9.20 1.93 5.43 0.65 0.0001 
#Albumin/ creatinine ratio (µg/g 
creatinine) 
71.94 73.49 20.53 26.27 0.02 
Cholesterol (mg/dl) 194.86 63.65 100.54 20.41 0.0001 
Triglyceride (mg/dl) 106.59 53.12 68.89 28.39 0.03 
HDL-c (mg/dl) 49.31 16.35 52.21 11.12 0.90 
LDL-c (mg/dl) 116.49 39.10 62.50 19.88 0.0001 
Image study 
     
cIMT (mm) 0.52 0.06 0.41 0.03 0.0001 
Resistivity index (RI) 0.67 0.04 0.59 0.02 0.03 
T-test for independent variables; # Mann Whitney U test was used; Median, mean ± SD 
(range); BMI: body mass index; HbA1c: glycosylated haemoglobin; LDL: Low-density 
lipoprotein; HDL: high-density lipoprotein; cIMT: carotid intimal medial thickness. 
 
Sclerodactyly was positive in 12 (19%) of 
patients (Table 2).  
Table 2: Frequency distribution of skin thickness in type 1 
diabetic patients 
Variables N % 
Diabetic Sclerodactyly   
Negative 51 81 
Positive 12 19 
 
Patients with sclerodactyly have significantly 
thickened skin with skin thickness of 0.9 + 0.09 mm 
compared to patients without scleroductyly and 
controls (skin thickness was 0.69 + 0.07 mm and 0.68 
+ 0.11 mm respectively, P = 0.0001 (Table 3).  
Table 3: Comparison between maximal skin thickness in 
people with diabetes (with and without clinical symptoms) and 
controls 
Variables 
Patients 
Controls 
P-value Negative clinically Positive clinically 
Mean SD Mean SD Mean SD 
Sclerodactyly 0.69 0.07 0.90 0.09 0.68 0.11 0.0001 
One-way ANOVA test is used followed by post HOCC test; Patients with clinical symptoms 
have significantly higher skin thickness than control, and patient without waxy skin while 
no difference between patients without waxy skin and control. 
 
Male diabetic patients had significantly higher 
skin thickness (Table 4).  
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Table 4: Comparison between skin thicknesses in diabetic 
patients about sex 
Variables 
Males Female 
P-value 
Mean SD Mean SD 
Skin thickness 0.77 0.10 0.65 0.08 0.0001 
 
Systolic blood pressure, albumin/creatinine 
ratio, cholesterol, triglyceride, cIMT were significantly 
higher, while HDL-c was significantly lower in people 
with diabetes with positive skin thickness (Table 5). 
Table 5: Comparison between diabetic patients about skin 
thickness 
Variables 
Skin thickness 
 
Negative 
N = 51 
Positive 
N = 12 P-value 
Mean SD Mean SD 
Demographic data 
     
Age (yrs) 15.59 1.95 16.10 1.39 0.40 
Duration of disease (yrs) 8.63 3.11 9.15 2.46 0.60 
Insulin dose (u/kg) 1.49 0.47 1.39 0.41 0.50 
Blood pressure 
     
Systolic blood pressure (mmHg) 116.57 11.36 125.45 12.93 0.03 
Diastolic blood pressure 
(mmHg) 
82.71 9.95 83.18 7.17 0.90 
Anthropometric data 
     
Waist circumference (cm) 83.57 10.53 84.36 8.69 0.80 
Hip circumference (cm) 92.34 8.99 92.18 6.47 0.90 
Waist/hip ratio 0.90 0.07 0.92 0.07 0.70 
waist/height ratio 0.52 0.07 0.49 0.06 0.20 
BMI (SDS) 1.26 1.09 1.35 1.00 0.80 
BMI (kg/m
2
) 25.11 4.89 24.62 3.63 0.80 
Laboratory data 
     
HBA1 % 9.08 1.68 9.72 1.73 0.30 
Albumin/creatinine ratio (µg/g 
creatinine) 
17.73 14.25 63.44 201.40 0.05 
Uric acid (mg/dl) 4.17 1.09 3.84 0.77 0.50 
OXLDL (mg/dl) 17.91 5.82 18.19 6.27 0.90 
Cholesterol (mg/dl) 168.83 42.20 202.55 70.35 0.05 
Triglyceride (mg/dl) 73.67 21.95 124.29 93.64 0.004 
HDL-c (mg/dl) 56.85 23.14 46.25 
 
10.77 
0.04 
LDL-c (mg/dl) 107.90 40.18 119.72 51.35 0.40 
VLDL-c (mg/dl) 12.95 3.74 19.12 8.26 0.07 
Image study 
     
Common carotid intimal medial 
thickness (mm) 
0.48 0.08 0.51 0.05 0.03 
Resistivity index (RI) 0.60 0.03 0.62 0.06 0.20 
T-test for independent variables; # Mann Whitney U test was used; Median, mean ± SD 
(range); BMI: body mass index; HbA1c: glycosylated haemoglobin; LDL: Low-density 
lipoprotein; HDL: high-density lipoprotein; cIMT: carotid intimal medial thickness. 
 
Sclerodactyly had a significant positive 
correlation with age of diabetics, waist/height ratio, 
HbA1c, albumin/creatinine ratio, triglyceride and cIMT 
(Table 6). 
Table 6: Correlation between skin thickness with 
demographics, laboratory data and carotid intimal medial 
thickness in type 1 diabetic patients 
Variables 
Skin thickness 
r P-value 
Demographic data 
 
 
Age (yr) 0.29 0.02 
Duration of disease (yr) 0.24 0.06 
Insulin dose (u/kg) 0.13 0.40 
Anthropometric data 
 
 
Waist/hip ratio 0.03 0.83 
Waist/height ratio 0.31 0.04 
Blood pressure 
 
 
Systolic blood pressure 
(mmHg) 
0.33 0.03 
Diastolic blood pressure 
(mmHg) 
0.02 0.91 
Laboratory data 
 
 
HBA1 % 0.3 0.03 
Albumin/creatinine ratio (µg/g 
creatinine) 
0.3 0.03 
Uric acid (mg/dl) 0.07 0.78 
Cholesterol (mg/dl) -0.25 0.08 
Triglycerid (mg/dl) 0.35 0.01 
HDL-c (mg/dl) -0.16 0.26 
LDL-c (mg/dl) 0.13 0.38 
Image study 
 
 
Carotid intimal medial 
thickness (mm) 
0.20 0.01 
Resistivity index (RI) 0.17 0.31 
BMI: body mass index; HbA1c: glycosylated haemoglobin; LDL: Low-density lipoprotein; HDL: 
high-density lipoprotein; cIMT: carotid intimal medial thickness. 
Discussion 
 
Sclerodactyly is a part of limited joint mobility 
(LJM), appear in the form of hand stiffness with flexion 
contractures of the fingers with thickened tight waxy 
skin. Diabetic patients had skin changes without LJM, 
and it is known as “diabetic sclerodactyly” [8]. 
In the present study, people with diabetes had 
higher HbA1c, albumin/creatinine ratio, cholesterol, 
triglyceride, LDL-c, cIMT and renal arterial resistivity 
indices as well as the waist circumference & hip 
circumference. 
Our patients with sclerodactyly have 
significantly thickened skin with skin thickness of 0.9 ± 
0.09 mm, compared to patients without sclerodactyly 
and controls (skin thickness of 0.69 ± 0.07 mm and 
0.68 ± 0.11 mm respectively, (P = 0.0001). No 
significant difference was detected between patients 
without thickened waxy skin and control. Our findings 
are comparable to results of Seibold [8] who found 
skin changes in 34% of diabetic children compared 
with no skin changes in healthy children. 
In the current study, the incidence of 
sclerodactyly was 19%, and this is in line with recent 
studies [16], [17] that revealed a decreased frequency 
of LJM and sclerodactyly in comparison with the 
frequency 2 decades ago. Lindsay JR et al., [17], 
revealed that the presence of LJM and sclerodactyly 
has decreased from 43% to 23% between the 1980s 
and 2002 (P < 0.0001) and related this to better 
glycemic control and care of diabetics. On the other 
hand, most old studies reported incidences of LJM 
and sclerodactyly ranging from 8% to 58% of patients 
and average prevalence was about 30% to 40% [10], 
[14], [15]. 
In the present study, people with diabetes 
with sclerodactyly showed a significant positive 
correlation with age of diabetic patients and HbA1c. 
These findings are in agreement with those of Derraik 
et al., [25] who found a relationship between poor 
glycemic control and thickness of the dermis 
(p = 0.015), with an estimated thickening of 87 μm with 
every 1% increase in HbA1c (p < 0.0001). On the 
other hand, Lo et al., [29] and Tüzün et al., [30] 
reported that there is no relation between HbA1c and 
skin thickness or diabetic sclerodactyly, respectively. 
In the current study, male diabetic patients 
had significantly higher skin thickness. Systolic blood 
pressure, cholesterol, triglyceride and cIMT were 
significantly higher, while HDL-c was significantly 
lower in people with diabetes with positive skin 
thickness. These agree with Arkkila et al., [20] who 
reported that type 2 diabetic patients with LJM had 3.1 
and 4 fold higher risk of coronary heart disease and 
cerebrovascular disease, respectively. Another study 
revealed that type 1 diabetic women with LJM were 
associated with subclinical macroangiopathy (greater 
cIMT and a higher risk of plaques). On the contrary, 
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diabetic men with LJM were more likely to have 
proteinuria, retinopathy, and hypertension [31]. 
In our study, people with diabetes with 
sclerodactyly had a relationship with microalbuminuria 
and no relation with resistivity index (RI). Amin et al., 
[19], reported that albumin to creatinine ratio was 
insignificantly higher in patients with LJM and 
microalbuminuria increase with increasing duration of 
the disease by 1.9 fold and Rosenbloom et al., [9] 
reported that patients had an increased risk of 
clinically apparent microvascular disease (retinopathy 
and nephropathy) by more than 3 fold. Fitzcharles et 
al., [18] found a similar but less dramatic association 
of the microvascular disease with LJM in adult 
patients with DM. 
Sclerodactyly has the same pathogenetic link 
with systemic diabetic complications and ultrasound 
on the hand is easy, early detection of diabetic 
macrovascular and microvascular diseases which 
may be used as a screening method. 
In conclusion, ultrasound is an easy method 
for diagnosis of sclerodactyly. Increased prevalence of 
sclerodactyly in diabetic patients is high, and it is 
related to the presence of macrovascular and 
microvascular complications. Sclerodactyly may be 
used as a marker for early detection of diabetic 
vascular complications. 
We recommend frequent follow up of diabetic 
patients for early detection of sclerodactyly in 
uncontrolled diabetic patients that could be an 
alarming sign for microalbuminuria, hypertension, 
hyperlipidaemia and atherosclerosis. 
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